125 related articles for article (PubMed ID: 8869364)
1. A new approach in the evaluation of gonadotropins for the diagnosis of polycystic ovary syndrome.
Manieri C; Pastorino R; Marolda AR; Musso M; Boggio G; Fornengo R; Tagliabue M; Di Bisceglie C; Camanni F
Panminerva Med; 1995 Sep; 37(3):115-8. PubMed ID: 8869364
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
[TBL] [Abstract][Full Text] [Related]
3. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
4. The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome.
Cho LW; Jayagopal V; Kilpatrick ES; Holding S; Atkin SL
Ann Clin Biochem; 2006 May; 43(Pt 3):217-9. PubMed ID: 16704758
[TBL] [Abstract][Full Text] [Related]
5. [Inappropriate gonadotropin secretion in the polycystic ovary syndrome].
Pilotti L; Data PG; Di Tano G
Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1885-90. PubMed ID: 6440582
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin evaluation in the diagnosis of polycystic ovary syndrome using either a monoclonal or a polyclonal antibody radioimmunoassay.
Manieri C; Pastorino R; Marolda AR; Musso MC; Gellona A; Barberis A; Boggio G; Messina M
J Endocrinol Invest; 1992 Mar; 15(3):219-22. PubMed ID: 1624683
[TBL] [Abstract][Full Text] [Related]
7. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
Banaszewska B; Spaczyński RZ; Pelesz M; Pawelczyk L
Rocz Akad Med Bialymst; 2003; 48():131-4. PubMed ID: 14737959
[TBL] [Abstract][Full Text] [Related]
8. Plasma follicle-stimulating and luteinizing hormones and the macrosopic characteristics of the ovaries in patients with stein-leventhal syndrome. Response to LH-RH in Stein-Leventhal syndrome.
Valkov IM; Dokumov I
Endocrinologie; 1977; 15(1):55-8. PubMed ID: 322249
[TBL] [Abstract][Full Text] [Related]
9. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
[TBL] [Abstract][Full Text] [Related]
10. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
[TBL] [Abstract][Full Text] [Related]
11. Serum LH and FSH levels in women with polycystic ovary syndrome before and after ovarian wedge resection.
Shterev AD; Dokumov SI
Endocrinologie; 1982; 20(3):203-7. PubMed ID: 6815773
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome or hyperprolactinaemia: a study of mild hyperprolactinaemia.
Su HW; Chen CM; Chou SY; Liang SJ; Hsu CS; Hsu MI
Gynecol Endocrinol; 2011 Jan; 27(1):55-62. PubMed ID: 20504100
[TBL] [Abstract][Full Text] [Related]
13. Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following Gn-RH administration.
Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
Int J Fertil; 1992; 37(2):111-4. PubMed ID: 1349592
[TBL] [Abstract][Full Text] [Related]
14. [Is increased secretion of LH after LHRH administration a reliable indicator of polycystic ovary syndrome?].
Steck T; Petraki S; Baseler C; Albert PJ; Wernze H
Gynakol Rundsch; 1991; 31 Suppl 2():328-31. PubMed ID: 1790969
[No Abstract] [Full Text] [Related]
15. [Hypophyseal gonadotropins after GnRH in patients with pituitary tumors].
Morosini PP; Carletti P; Campanella N; Ferretti GF
Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1243-7. PubMed ID: 6779829
[TBL] [Abstract][Full Text] [Related]
16. Response of gonadotropins to pituitary stimulation with luteinizing hormone releasing hormone is a more specific than sensitive parameter for the polycystic ovary syndrome.
Steck T; Wernze H; Albert PJ
Gynecol Endocrinol; 1991 Dec; 5(4):235-47. PubMed ID: 1796746
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
18. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinaemia in polycystic ovary syndrome.
Lunde O
Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
[TBL] [Abstract][Full Text] [Related]
20. [LH-FSH ratio and Polycystic Ovary Syndrome: A forgotten test?].
Saucedo de la Llata E; Moraga-Sánchez MR; Romeu-Sarrió A; Carmona-Ruiz IO
Ginecol Obstet Mex; 2016 Feb; 84(2):84-94. PubMed ID: 27290835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
